Published in J Urol on March 01, 2005
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
The impact of Improving Outcomes Guidance on the management and outcomes of patients with carcinoma of the penis. Ann R Coll Surg Engl (2010) 1.39
Contemporary inguinal lymph node dissection: minimizing complications. World J Urol (2008) 1.00
Robotic-assisted inguinal lymph node dissection: A preliminary report. Indian J Urol (2011) 0.99
Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97
Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol (2008) 0.95
Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int (2013) 0.92
Extra-anatomical transobturator bypass graft for femoral artery involvement by metastatic carcinoma of the penis: report of five patients. World J Urol (2008) 0.90
Metastatic penile carcinoma - an update on the current diagnosis and treatment options. Cent European J Urol (2014) 0.89
Video Endoscopic Inguinal Lymphadenectomy (VEIL)--a prospective critical perioperative assessment of feasibility and morbidity with points of technique in penile carcinoma. World J Surg Oncol (2013) 0.85
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res (2009) 0.85
What next? Managing lymph nodes in men with penile cancer. Can Urol Assoc J (2008) 0.84
Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer. BMC Urol (2013) 0.82
How accurate are present risk group assignment tools in penile cancer? World J Urol (2008) 0.79
Preemptive lymphadenectomy markedly improves survival in patients with cancer of the penis who harbor occult metastases. J Urol (2005) 0.78
Penile cancer: Optimal management of T1G2 penile cancer remains unclear. Nat Rev Urol (2012) 0.77
Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection. World J Urol (2015) 0.77
Strongly magnetic iron nanoparticles improve the diagnosis of small tumours in the reticuloendothelial system by magnetic resonance imaging. PLoS One (2013) 0.77
Epigenetic mechanisms in penile carcinoma. Int J Mol Sci (2013) 0.77
Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines. BMC Urol (2015) 0.76
Sentinel lymph node biopsy in renal malignancy: The past, present and future. World J Nephrol (2016) 0.75
Tumor histologic grade is the most important prognostic factor in patients with penile cancer and clinically negative lymph nodes not submitted to regional lymphadenectomy. Int Braz J Urol (2016) 0.75
Feasibility of performing dynamic sentinel lymph node biopsy as a delayed procedure in penile cancer. World J Urol (2015) 0.75
Radioguided surgery in urological malignancies. Indian J Urol (2008) 0.75
Clinicopathologic Characteristics and Treatment Outcomes of Penile Cancer. World J Mens Health (2017) 0.75
Penile cancer: Perspective from a Canadian tertiary care centre. Can Urol Assoc J (2015) 0.75
Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: clinical outcomes with a minimum 48 months follow-up study. Korean J Urol (2015) 0.75
Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer. Int Braz J Urol (2015) 0.75
Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach. Eur J Nucl Med Mol Imaging (2016) 0.75
More precise prediction in Chinese patients with penile squamous cell carcinoma: protein kinase CK2α catalytic subunit (CK2α) as a poor prognosticator. Oncotarget (2017) 0.75
Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China. J Cancer Res Clin Oncol (2014) 0.75
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer (2003) 2.40
How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol (2004) 2.29
Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Systematic review and meta-analysis of laparoscopic versus open colectomy with end ileostomy for non-toxic colitis. Br J Surg (2013) 2.11
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg (2013) 1.98
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol (2011) 1.73
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. Eur J Surg Oncol (2008) 1.69
Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol (2006) 1.67
Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. J Urol (2011) 1.64
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg (1996) 1.54
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. J Surg Oncol (2005) 1.52
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg (2004) 1.46
Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol (2002) 1.46
Sequential treatment for recurrent localized prostate cancer. J Surg Oncol (2008) 1.45
Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol (2008) 1.45
Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg (2007) 1.43
[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer]. Ned Tijdschr Geneeskd (2004) 1.40
[Incidence and treatment of prostatic carcinoma in the region of the Comprehensive Cancer Center Amsterdam, 1989-1994]. Ned Tijdschr Geneeskd (1996) 1.40
Finding lymph node metastases in invasive breast cancer: sampling or sentinel node procedure? Eur J Surg Oncol (2002) 1.39
[Internal radiotherapy in prostatic carcinoma; disappointing long-term results of retropubic Iodine-125 implantation]. Ned Tijdschr Geneeskd (1996) 1.38
[Less mutilating treatment of penile carcinoma]. Ned Tijdschr Geneeskd (2005) 1.35
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med (2000) 1.25
Upper urinary tract cancer: location is correlated with prognosis. Eur Urol (2005) 1.24
A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer (2009) 1.22
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol (1999) 1.22
EAU Guidelines on Penile Cancer. Eur Urol (2004) 1.19
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol (2001) 1.19
Perineal hernia repair after abdominoperineal resection: a pooled analysis. Colorectal Dis (2012) 1.18
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J Urol (2005) 1.18
Sarcomatoid squamous cell carcinoma of the penis: a clinical and pathological study of 5 cases. J Urol (2004) 1.16
The definition of a sentinel node. Ann Surg Oncol (2001) 1.15
Morbidity of dynamic sentinel node biopsy in penile carcinoma. J Urol (2005) 1.15
Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg (2000) 1.13
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol (1997) 1.13
Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. Ann Oncol (2010) 1.12
Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer. Ann Oncol (1994) 1.10
The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging (2002) 1.10
[The course of prostatic carcinoma]. Ned Tijdschr Geneeskd (1995) 1.07
[Iodine-125 implantation in localized cancer of the prostate; too early for rejoicing]. Ned Tijdschr Geneeskd (1998) 1.07
Response to Jensen et al. (2014): pelvic floor reconstruction with a biological mesh after extralevator abdominoperineal excision leads tolow wound complications and perineal hernia rates with minor movement limitations. Colorectal Dis (2014) 1.06
Factors determining delay in relaparotomy for anastomotic leakage after colorectal resection. World J Gastroenterol (2007) 1.06
History of sentinel node and validation of the technique. Breast Cancer Res (2001) 1.05
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol (2001) 1.04
Bridge-to-surgery stent placement versus emergency surgery for acute malignant colonic obstruction. Br J Surg (2014) 1.02
Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl (2000) 1.01
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer (1998) 1.01
Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial. Br J Surg (2014) 1.00
EAU guidelines on penile cancer. Eur Urol (2002) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging (2009) 0.98
Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol (2000) 0.98
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol (2007) 0.98
Vascular complications of isolated limb perfusion. Eur J Surg Oncol (1998) 0.97
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol (2000) 0.96
Sentinel node biopsy for melanoma in the head and neck region. Head Neck (2000) 0.96
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Ann Oncol (2012) 0.94
Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol (2006) 0.94
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma. Br J Cancer (1998) 0.94
The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol (2002) 0.93
Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol Suppl (2000) 0.93
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys (1998) 0.93
Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg (2001) 0.93
Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma. Melanoma Res (1995) 0.93
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma. Br J Cancer (2003) 0.92
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg (2007) 0.92
Laser therapy for carcinoma in situ of the penis. J Urol (2001) 0.92
Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med (1998) 0.92
Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol (2003) 0.91
Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol (2005) 0.91
Identification and biopsy of the sentinel lymph node in breast cancer. Eur J Surg Oncol (1998) 0.90
Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg (1996) 0.90
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J Am Coll Surg (1999) 0.90
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Ann Surg Oncol (1999) 0.89
Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol (2002) 0.89
The place of radiation therapy as definitive treatment of bladder cancer. Int J Urol (1995) 0.89
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer (2000) 0.89
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer (2002) 0.89
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience. Eur J Surg Oncol (2013) 0.88
Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors. J Surg Oncol (1997) 0.88